When new cancer drugs are shown to be largely ineffective, exceptional cases of good outcome may pave the way for new treatments that could benefit a smaller group of patients.

Enzalutamide, a targeted therapy co-invented by a Memorial Sloan-Kettering investigator, has received FDA approval for the treatment of men with metastatic prostate cancer.

Dr. Finley, Co-Director of the Complex Airway Program, explains how he lays out a treatment plan with his patients, and determines which type of surgery fits best in the context of their lifestyle.

Dr. King talks about her research investigating why certain women develop breast cancer and about the long-term relationships she maintains with her patients.

Watch urologic surgeon Karim Touijer discuss our comprehensive approach to cancer care and recent advances in minimally invasive surgery.

Thoracic surgeon Inderpal Sarkaria discusses the expertise of Memorial Sloan-Kettering surgeons at performing complex operations to treat cancers of the lung, esophagus, and chest wall.

For the 23rd year in a row, Memorial Sloan-Kettering is ranked as one of the best hospitals for cancer care nationally according to U.S. News & World Report, appearing at No. 2 on the 2012-13 list.